241 related articles for article (PubMed ID: 21044013)
1. Cell reprogramming: a new chemical approach to stem cell biology and tissue regeneration.
Anastasia L; Piccoli M; Garatti A; Conforti E; Scaringi R; Bergante S; Castelvecchio S; Venerando B; Menicanti L; Tettamanti G
Curr Pharm Biotechnol; 2011 Feb; 12(2):146-50. PubMed ID: 21044013
[TBL] [Abstract][Full Text] [Related]
2. The standpoint of stem cell research.
Romano G
Drug News Perspect; 2008 Sep; 21(7):408-12. PubMed ID: 19259554
[TBL] [Abstract][Full Text] [Related]
3. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
Chen H; Zuo Q; Wang Y; Song J; Yang H; Zhang Y; Li B
BMC Biotechnol; 2017 Feb; 17(1):11. PubMed ID: 28193206
[TBL] [Abstract][Full Text] [Related]
4. Testicular germline stem cells.
Kee K; Pera RA; Turek PJ
Nat Rev Urol; 2010 Feb; 7(2):94-100. PubMed ID: 20084076
[TBL] [Abstract][Full Text] [Related]
5. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
6. Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate.
Yamaguchi S; Hirano K; Nagata S; Tada T
Stem Cell Res; 2011 Mar; 6(2):177-86. PubMed ID: 21130722
[TBL] [Abstract][Full Text] [Related]
7. Examining the therapeutic potential of various stem cell sources for differentiation into insulin-producing cells to treat diabetes.
Pan G; Mu Y; Hou L; Liu J
Ann Endocrinol (Paris); 2019 Feb; 80(1):47-53. PubMed ID: 30041820
[TBL] [Abstract][Full Text] [Related]
8. Somatic Cell Reprogramming Informed by the Oocyte.
Gonzalez-Munoz E; Cibelli JB
Stem Cells Dev; 2018 Jul; 27(13):871-887. PubMed ID: 29737235
[TBL] [Abstract][Full Text] [Related]
9. Regenerating the kidney using human pluripotent stem cells and renal progenitors.
Becherucci F; Mazzinghi B; Allinovi M; Angelotti ML; Romagnani P
Expert Opin Biol Ther; 2018 Jul; 18(7):795-806. PubMed ID: 29939787
[TBL] [Abstract][Full Text] [Related]
10. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
[TBL] [Abstract][Full Text] [Related]
11. Develop-WNTs in somatic cell reprogramming.
Merrill BJ
Cell Stem Cell; 2008 Nov; 3(5):465-6. PubMed ID: 18983957
[TBL] [Abstract][Full Text] [Related]
12. Pavia symposium on embryos and stem cells.
Boiani M; Crosetto N; Redi CA
Eur J Histochem; 2008; 52(1):79-81. PubMed ID: 18502727
[No Abstract] [Full Text] [Related]
13. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
Anastasia L; Pelissero G; Venerando B; Tettamanti G
Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
[TBL] [Abstract][Full Text] [Related]
14. Origin of stem cells in organogenesis.
Slack JM
Science; 2008 Dec; 322(5907):1498-501. PubMed ID: 19056975
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming of endometrial adult stromal cells in the presence of a ROCK inhibitor, thiazovivin, could obtain more efficient iPSCs.
Mohseni R; Shoae-Hassani A; Verdi J
Cell Biol Int; 2015 May; 39(5):515-8. PubMed ID: 25490878
[TBL] [Abstract][Full Text] [Related]
16. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
Menon S; Shailendra S; Renda A; Longaker M; Quarto N
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
[TBL] [Abstract][Full Text] [Related]
17. Stem cell therapies to treat muscular dystrophy: progress to date.
Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
[TBL] [Abstract][Full Text] [Related]
18. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs.
Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L
Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptors in stem cells and their therapeutic potential.
Sun G; Shi Y
Adv Drug Deliv Rev; 2010 Oct; 62(13):1299-306. PubMed ID: 20708051
[TBL] [Abstract][Full Text] [Related]
20. Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells.
Boraas LC; Guidry JB; Pineda ET; Ahsan T
PLoS One; 2016; 11(1):e0145084. PubMed ID: 26771179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
